Circadian Biology and Biological Clocks

Introduction to Circadian Biology

Circadian clocks are self-sustaining molecular oscillators with approximately 24-hour periodicity (from Latin circa diem, 'about a day') that coordinate biological processes with the daily light-dark cycle. Nearly all organisms from cyanobacteria to mammals possess circadian clocks, reflecting the fundamental importance of anticipating predictable environmental changes over evolutionary time. Circadian clocks regulate sleep-wake cycles, body temperature, feeding, hormone secretion, metabolism, gene expression (~40% of protein-coding genes in mammals are expressed rhythmically), cell division timing, drug metabolism, immune function, and tissue repair. Disruption of circadian alignment—by shift work, jet lag, or social jet lag—is associated with increased risk of metabolic syndrome, cancer, cardiovascular disease, depression, and impaired immune function.

The 2017 Nobel Prize in Physiology or Medicine was awarded to Jeffrey Hall, Michael Rosbash, and Michael Young for their work elucidating the molecular mechanism of the circadian clock—discovering the period, timeless, clock, cycle, and cryptochrome genes in Drosophila and demonstrating how they form the transcriptional-translational feedback loop (TTFL) driving ~24-hour oscillations. The molecular clock is cell-autonomous—virtually every cell in an organism contains a functional circadian clock—but peripheral clocks are synchronised (entrained) to the master clock in the suprachiasmatic nucleus (SCN) of the hypothalamus, which is itself entrained by light signals through intrinsically photosensitive retinal ganglion cells (ipRGCs) containing melanopsin.

Molecular Clock Mechanism

CLOCK-BMAL1 Feedback Loop

The mammalian circadian clock is built on an interlocking transcription-translation feedback loop. Core positive elements: CLOCK and BMAL1 form heterodimers binding E-box elements, driving transcription of Per1/2/3 and Cry1/2 genes. Core negative elements: PER and CRY proteins accumulate throughout the day, then in late evening form repressive complexes that enter the nucleus to inhibit CLOCK-BMAL1 transcription—reducing their own expression. As PER/CRY complexes are gradually degraded (CK1epsilon/delta phosphorylates PER targeting it for beta-TrCP ubiquitin E3 ligase-mediated degradation), inhibition is relieved and a new cycle begins. The full cycle takes ~24 hours—with a Q10 of ~1 (unusually temperature-compensated for a biochemical process). Accessory loops involving REV-ERBalpha/beta (repressive) and ROR (activating) nuclear receptors targeting Bmal1 provide additional stability.

SCN Master Clock and Entrainment

The bilateral suprachiasmatic nuclei (SCN, ~20,000 neurons per hemisphere) serve as the master circadian pacemaker in mammals. Light information reaches the SCN through the retinohypothalamic tract (RHT) from melanopsin-containing ipRGCs—light induces Per1/2 expression in SCN through CRE (cAMP Response Element) and SERUM (SRE) sites, phase-shifting the clock. SCN neurons are electrically and synaptically coupled, producing synchronised oscillations with less cell-to-cell variability than peripheral clocks. After SCN ablation, rodents free-run with individual tissue clock periodicities diverging from each other—demonstrating the SCN's role in coordinating peripheral clocks. Peripheral clock synchronisation uses SCN-derived humoral signals (melatonin, glucocorticoids, feeding-responsive signals via autonomic innervation, and body temperature rhythms)—core temperature nadir at 4-5am before waking is a potent circadian signal.

Circadian Regulation of Physiology

Circadian Metabolism

Metabolic processes are extensively regulated by the circadian clock—and metabolic signals feedback to regulate clock gene expression. NAD+/NAMPT (key for clock-associated SIRT1 activity), AMPK (activating CRY1 degradation), and mTOR (controlling PER2 nuclear translocation) create bidirectional coupling between metabolism and clock. Insulin sensitivity peaks in the morning; glucagon sensitivity in the evening—explaining why identical caloric meals consumed at different times cause different glycaemic responses (morning meals lower peak glucose than evening meals). Hepatic lipid synthesis and very-low-density lipoprotein (VLDL) secretion peak in the late active phase; bile acid synthesis gates to the active phase driven by CLOCK-BMAL1 activity on CYP7A1. Time-restricted eating (TRF) aligned with the active phase improves metabolic biomarkers partly through reinforcing circadian alignment in metabolic tissues.

Circadian Medicine

Chronotherapy—timing therapeutic interventions to maximise efficacy and minimise toxicity based on circadian pharmacokinetics and pharmacodynamics—improves outcomes across multiple diseases. Cancer cell division rates, DNA repair capacity, and drug metabolism enzymes all vary with time-of-day; evening cisplatin or oxaliplatin delivery reduces nephrotoxicity and neurotoxicity in some regimens. Blood pressure peaks in the morning (morning surge—associated with morning peak in myocardial infarctions and stroke); antihypertensive medications taken at bedtime may provide better circadian blood pressure control. Inhaled corticosteroids for asthma (symptoms peak at night from circadian-driven mast cell degranulation) are most effective when taken in the evening. Clinical chronotherapy trials for cancer (TEMPO, OPTINIV) use programmable pumps to optimally time chemotherapy delivery based on circadian biomarker profiles.

Examples and Applications

Example 1: Familial Advanced Sleep Phase Syndrome

FASPS—an autosomal dominant sleep disorder causing extreme morning preference (sleeping 7:30pm-3:30am) without distress—is caused by mutations in circadian clock genes. hPER2 S662G mutation in one family reduces CK1epsilon/delta phosphorylation of PER2—impairing the sequential phosphorylation cascade marking PER2 for degradation, stabilising PER2, shortening the period and advancing the phase. CK1delta T44A mutation in another family reduces CK1delta activity with similar consequences. These human genetics discoveries validated the CK1-PER2 phosphorylation cascade as the clock period-determination mechanism—connecting Drosophila and mouse circadian genetics to human sleep phenotypes. CK1 inhibitors and PER modifiers are pharmacological targets for shifting circadian phase in shift workers, jet-lagged travellers, and delayed sleep phase disorder patients.

Example 2: Circadian Disruption and Cancer Risk

Shift work is classified as a Group 2A (probable human carcinogen) by the International Agency for Research on Cancer (IARC) based on epidemiological associations with breast, prostate, and bowel cancer risk. Mechanistically, circadian disruption impairs: WEE1 kinase and CHK1-mediated circadian gating of cell division (cells in S-phase overnight when DNA repair capacity is low have elevated mutation rates); immune surveillance (NK cell activity peaks in the active phase; their timing disruption impairs tumour immune surveillance); and melatonin production (darkness-suppressed melatonin exposure during daytime sleep of night shift workers reduces a potential anti-proliferative oncostatic signal). BMAL1 knockout mice develop earlier onset of radiation-induced cancer and show accelerated tumour growth in xenograft models, directly linking clock machinery to cancer suppression.

Example 3: Jet Lag Biology

Jet lag arises when rapid transmeridional travel desynchronises internal circadian clocks from the new local time. The SCN re-entrains at ~1-2 hours per day; peripheral clocks in liver and gut re-entrain faster to feeding times and meal cues. East-bound travel (phase advance) is harder than westbound (phase delay) because the human endogenous period averages ~24.2 hours—slightly longer than 24 hours making delay easier than advance. Timed melatonin (exogenous melatonin taken at local bedtime) accelerates SCN re-entrainment by signalling through SCN melatonin receptors (MT1, MT2) inhibiting SCN neuronal firing. Strategic light exposure (morning light for phase advance, evening light for phase delay) precisely targets the phase response curve (PRC) of the SCN to accelerate entrainment. Tasimelteon (Hetlioz)—an MT1/MT2 agonist—is approved for Non-24-Hour Sleep-Wake Disorder in blind patients lacking photic entrainment.

Example 4: The Immune Clock

Innate and adaptive immune responses have pervasive circadian organisation. TLR-dependent cytokine production (TNF, IL-6, IL-12) by macrophages peaks in the morning (active phase) in mice; vaccine responses (antibody titres after influenza vaccination) are significantly higher when vaccines are administered in the morning. Sepsis mortality in hospitalised patients varies with time of day—septic shock mortality is highest in the early morning. T cell trafficking from blood to lymph nodes is circadian (CCR7 expression peaks in early rest phase in mice); tumour-infiltrating T cell density in human biopsies varies by time surgery is performed—early morning tumour resection correlates with improved survival in retrospective studies. Clock-disrupted mice (BMAL1 KO, CRY1/2 KO) mount exaggerated inflammatory responses due to loss of circadian inhibition of NF-kappaB.

Example 5: Time-Restricted Eating Biology

Time-restricted eating (TRE)/time-restricted feeding (TRF)—limiting caloric intake to a 6-10 hour window aligned with the active phase—independently of calorie restriction improves multiple metabolic and circadian endpoints in mice and preliminary human studies. Mechanisms include: restoring robust liver clock gene oscillations dampened by ad libitum eating throughout dark and light phases; reducing hepatic lipogenesis during the rest phase; improving insulin sensitivity through circadian-aligned mTOR and AMPK regulation; reinforcing gut microbiome composition rhythms; reducing adipose tissue inflammation. Satchidananda Panda's laboratory showed that mice on high-fat diets but restricted to 8-hour feeding were protected from obesity, metabolic syndrome, and liver steatosis compared to ad libitum controls consuming the same calories—primarily through circadian mechanisms rather than caloric difference. Human TRF trials show improved fasting glucose, blood pressure, and oxidative stress markers.

Example 6: Melatonin Biology

Melatonin, produced exclusively at night by the pineal gland in a temperature-dependent, light-suppressible rhythm, serves as a circulating hormonal signal of darkness and night duration to the body—a chemical encoding of photoperiod/season. Melatonin is synthesised from tryptophan through serotonin in a two-step pathway: AANAT (arylalkylamine N-acetyltransferase, rate-limiting, acutely regulated by beta-adrenergic cues from SCN) and ASMT (acetylserotonin O-methyltransferase). Melatonin acts through MT1 (inhibiting SCN neuronal firing, mediating sleep onset) and MT2 receptors (phase-shifting effects). Even brief light exposure at night (blue light, 480nm, maximally activating melanopsin in ipRGCs) suppresses melatonin beginning within 5 minutes—the mechanistic basis for screen-use before bed disrupting sleep onset. Chronic low melatonin from artificial light at night is proposed to contribute to cancer, metabolic, and reproductive health effects.

Example 7: Chronotype and Genetics

Chronotype—individual preference for morning (lark) or evening (owl) activity timing—has substantial heritability (~50%) with genetic variants in CRY1, RORC, FBXL3, and dozens of GWAS loci including PER3 (Variable Number Tandem Repeat—5-repeat homozygotes are morning types; 4-repeat evening types). A severe delayed sleep phase disorder DSPD variant in CRY1 (CRY1 c.1657+3A>C frameshift causing truncated CRY1) lengthens the circadian period to 24.5 hours causing persistent delay that cannot entrain to 24-hour social schedules—autosomal dominant, affecting ~1 in 75 individuals. Social jet lag—the discrepancy between biological clock timing and social obligations (work/school start times misaligned with chronotype)—averages 1.5-2 hours in the population and is associated with obesity, metabolic syndrome, and cardiovascular risk independent of sleep duration.

Example 8: Circadian Clock in Cell Division and Cancer

The circadian clock gates cell division through timing of WEE1 kinase (inhibiting CDK1) and CDC25A phosphatase (activating CDK1) expression—both circadian-regulated to restrict mitosis to the appropriate time of day. WEE1 peaks during S-phase (subjective day in mice) reducing CDK1 activity and ensuring DNA replication is completed before mitosis; CDK1 activity peak in the late active phase allows G2/M progression at the correct time. Clock mutations (Bmal1 KO, Clock mutant) accelerate tumourigenesis in cancer models; loss of PER1/2 in human cancers correlates with poor prognosis. CLOCK mutations in some cancers hyperactivate DNA-damage-induced transcription; cryptochrome loss deregulates the CLOCK transcriptional programme affecting hundreds of cancer-relevant target genes. Understanding the cell cycle clock gate enables scheduling DNA-damaging cancer therapies to maximise tumour cell vulnerability and minimise normal tissue damage.

Try it live

Everything above runs in your browser — open Circadian Clock & SCN Entrainment Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.